Enhanced Escherichia coli adherence and invasion in Crohn’s disease and colon cancer 1 1The authors thank Professor T. K. Korhonen (Division of General Microbiology, University of Helsinki, Finland), who kindly donated Escherichia coli IH11165; Professor J.-F. Colombel (Laboratoire de Recherche sur les Maladies Inflammatoire de l’Intestine, Centre Hospitalier Universitaire, Lille, France) and Professor A. Darfeuille-Michaud (Faculte de Pharmacie, Clermont-Ferrand, France), who kindly donated the Crohn’s disease ileal isolates LF10 and LF82; and Dr. Keith Leiper (Gastroenterology Unit, Royal Liverpool & Broadgreen University Hospitals Trust, Liverpool, UK) for his cooperation in obtaining colorectal tissue specimens.As a consequence of the work described herein, a patent application has been filed by the University of Liverpool regarding the use of soluble plantain fiber in Crohn’s disease.
Helen Martin(Mersey Care NHS Trust), Jonathan M. Rhodes(University of Liverpool)
Cited by 714
Related Papers
Helicobacter pylori infection prevents allergic asthma in mouse models through the induction of regulatory T cells
|Journal of Clinical Investigation|2011|468
Effective treatment of allergic airway inflammation with <i>Helicobacter pylori</i> immunomodulators requires BATF3-dependent dendritic cells and IL-10
|Proceedings of the National Academy of Sciences|2014|122
Protein Phosphatase 2A, a Negative Regulator of the ERK Signaling Pathway, Is Activated by Tyrosine Phosphorylation of Putative HLA Class II-associated Protein I (PHAPI)/pp32 in Response to the Antiproliferative Lectin, Jacalin
|Journal of Biological Chemistry|2004|75
The Wnt/β-Catenin Pathway Attenuates Experimental Allergic Airway Disease
|The Journal of Immunology|2014|49
TLR3 but Not TLR7/8 Ligand Induces Allergic Sensitization to Inhaled Allergen
|The Journal of Immunology|2012|41